{"count": 5, "results": [{"_id": "38108689", "pmid": 38108689, "pmcid": "PMC10732090", "title": "Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis", "journal": "Invest Ophthalmol Vis Sci", "authors": ["Zhang JY", "Xiao J", "Xie B", "Barba H", "Boachie-Mensah M", "Shah RN", "Nadeem U", "Spedale M", "Dylla N", "Lin H", "Sidebottom AM", "D'Souza M", "Theriault B", "Sulakhe D", "Chang EB", "Skondra D"], "date": "2023-12-01T00:00:00Z", "doi": "10.1167/iovs.64.15.21", "meta_date_publication": "2023 Dec 1", "meta_volume": "64", "meta_issue": "15", "meta_pages": "21", "score": 50276.004, "text_hl": "Oral @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Inhibits @<m>DISEASE_Choroidal_Neovascularization</m> @DISEASE_MESH:D020256 @@@Choroidal Neovascularization@@@ by Modulating the Gut-Retina Axis", "citations": {"NLM": "Zhang JY, Xiao J, Xie B, Barba H, Boachie-Mensah M, Shah RN, Nadeem U, Spedale M, Dylla N, Lin H, Sidebottom AM, D'Souza M, Theriault B, Sulakhe D, Chang EB, Skondra D. Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):21. PMID: 38108689", "BibTeX": "@article{38108689, title={Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis}, author={Zhang JY and Xiao J and Xie B and Barba H and Boachie-Mensah M and Shah RN and Nadeem U and Spedale M and Dylla N and Lin H and Sidebottom AM and D'Souza M and Theriault B and Sulakhe D and Chang EB and Skondra D}, journal={Invest Ophthalmol Vis Sci}, volume={64}, number={15}, pages={21}}"}}, {"_id": "39518910", "pmid": 39518910, "title": "Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration.", "journal": "Int J Mol Sci", "authors": ["Xiao JF", "Luo W", "Mani A", "Barba H", "Solanki A", "Droho S", "Lavine JA", "Skondra D"], "date": "2024-10-22T00:00:00Z", "doi": "10.3390/ijms252111357", "meta_date_publication": "2024 Oct 22", "meta_volume": "25", "meta_issue": "21", "meta_pages": "", "score": 50271.176, "text_hl": "Intravitreal @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Protects Against @<m>DISEASE_Choroidal_Neovascularization</m> @DISEASE_MESH:D020256 @@@Choroidal Neovascularization@@@ and Light-Induced @DISEASE_Retinal_Degeneration @DISEASE_MESH:D012162 @@@Retinal Degeneration@@@.", "citations": {"NLM": "Xiao JF, Luo W, Mani A, Barba H, Solanki A, Droho S, Lavine JA, Skondra D. Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration. Int J Mol Sci. 2024 Oct 22;25(21):. PMID: 39518910", "BibTeX": "@article{39518910, title={Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration.}, author={Xiao JF and Luo W and Mani A and Barba H and Solanki A and Droho S and Lavine JA and Skondra D}, journal={Int J Mol Sci}, volume={25}, number={21}}"}}, {"_id": "34414094", "pmid": 34414094, "title": "Newly-found functions of metformin for the prevention and treatment of age-related macular degeneration.", "journal": "Int J Ophthalmol", "authors": ["Dang KR", "Wu T", "Hui YN", "Du HJ"], "date": "2021-08-18T00:00:00Z", "doi": "10.18240/ijo.2021.08.20", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "8", "meta_pages": "1274-1280", "score": 50267.133, "text_hl": "Recent studies have shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ can regulate @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism, inhibit @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, and prohibit retinal cell death and @<m>DISEASE_Choroidal_Neovascularization</m> @DISEASE_MESH:D020256 @@@CNV@@@ formation due to various pathological factors. ", "citations": {"NLM": "Dang KR, Wu T, Hui YN, Du HJ. Newly-found functions of metformin for the prevention and treatment of age-related macular degeneration. Int J Ophthalmol. 2021;14(8):1274-1280. PMID: 34414094", "BibTeX": "@article{34414094, title={Newly-found functions of metformin for the prevention and treatment of age-related macular degeneration.}, author={Dang KR and Wu T and Hui YN and Du HJ}, journal={Int J Ophthalmol}, volume={14}, number={8}, pages={1274-1280}}"}}, {"_id": "40965862", "pmid": 40965862, "title": "Metformin and the Development of Age-Related Macular Degeneration.", "journal": "JAMA Ophthalmol", "authors": ["Jindal DA", "Hanna J", "Shaia JK", "Markle J", "Rachitskaya A", "Kaelber DC", "Singh RP", "Talcott KE"], "date": "2025-09-18T00:00:00Z", "doi": "10.1001/jamaophthalmol.2025.3070", "meta_date_publication": "2025 Sep 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.863, "text_hl": "...Importance: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has demonstrated protective effects in systemic diseases, including @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@, @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@, and @DISEASE_Retinal_Diseases @DISEASE_MESH:D012164 @@@retinal diseases@@@, such as @DISEASE_Diabetic_Retinopathy @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ and @<m>DISEASE_Choroidal_Neovascularization</m> @DISEASE_MESH:D020256 @@@choroidal neovascularization@@@. ", "citations": {"NLM": "Jindal DA, Hanna J, Shaia JK, Markle J, Rachitskaya A, Kaelber DC, Singh RP, Talcott KE. Metformin and the Development of Age-Related Macular Degeneration. JAMA Ophthalmol. 2025 Sep 18;():. PMID: 40965862", "BibTeX": "@article{40965862, title={Metformin and the Development of Age-Related Macular Degeneration.}, author={Jindal DA and Hanna J and Shaia JK and Markle J and Rachitskaya A and Kaelber DC and Singh RP and Talcott KE}, journal={JAMA Ophthalmol}}"}}, {"_id": "28427181", "pmid": 28427181, "pmcid": "PMC5464828", "title": "Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK", "journal": "Oncotarget", "authors": ["Ying Y", "Ueta T", "Jiang S", "Lin H", "Wang Y", "Vavvas D", "Wen R", "Chen YG", "Luo Z"], "date": "2017-05-16T00:00:00Z", "doi": "10.18632/oncotarget.15825", "meta_date_publication": "2017 May 16", "meta_volume": "8", "meta_issue": "20", "meta_pages": "32794-32806", "score": 50055.69, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits laser-induced @<m>DISEASE_Choroidal_Neovascularization</m> @DISEASE_MESH:D020256 @@@choroidal neovascularization@@@", "citations": {"NLM": "Ying Y, Ueta T, Jiang S, Lin H, Wang Y, Vavvas D, Wen R, Chen YG, Luo Z. Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK Oncotarget. 2017 May 16;8(20):32794-32806. PMID: 28427181", "BibTeX": "@article{28427181, title={Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK}, author={Ying Y and Ueta T and Jiang S and Lin H and Wang Y and Vavvas D and Wen R and Chen YG and Luo Z}, journal={Oncotarget}, volume={8}, number={20}, pages={32794-32806}}"}}]}